Viewing Study NCT05366218

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-08 @ 4:44 AM
Study NCT ID: NCT05366218
Status: RECRUITING
Last Update Posted: 2024-12-12
First Post: 2022-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tafasitamab (MOR00208) in Pediatric Patients with Relapsed or Refractory Acute B Lineage Leukemia
Sponsor: University Hospital Tuebingen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ALL, Childhood B-Cell View
None Acute Lymphoid Leukemia Relapse View
None Acute Lymphocytic Leukemia Refractory View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD19 positive View
None refractory to standard treatment View
None relapse View